Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 46.75
-0.05 (-0.11%)
Jan 22, 2026, 1:35 PM CST
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.78 billion as of January 21, 2026. Its market cap has decreased by -9.70% in one year.
Market Cap
3.78B
Enterprise Value
3.05B
Revenue
792.49M
Ranking
n/a
PE Ratio
18.07
Stock Price
46.75
Market Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.78B, an increase of 7.12%. That is a compound annual growth rate of 0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.78B | 9.35% |
| Dec 31, 2025 | 3.45B | -20.87% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 8.25B |
| Pacific Hospital Supply | 6.04B |
| Formosa Optical Technology | 5.93B |
| St.Shine Optical | 5.82B |
| SciVision Biotech | 5.79B |
| ICARES Medicus | 3.97B |
| Nang Kuang Pharmaceutical | 3.69B |
| Bionime | 3.63B |